Our subsidiaries within Specialty Pharmaceuticals develop and supply registered, compounded, and licensed medicines—to pharmacies, the pharmaceutical industry, as well as regional authorities and municipalities. It is a market defined by strict regulatory requirements, high barriers to entry, and stable demand, creating the foundation for long-term customer relationships and recurring revenue.
Through investments in product development, collaborative research, and acquisitions, we are expanding our portfolio of proprietary medicines. In a relatively short time, we have built a significant pipeline for Unimedic Pharma, and we remain focused on continuing this work. At the same time, we are evaluating complementary acquisitions of well-established and medically well-justified products.
